Literature DB >> 19221081

Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.

Paul Ritvo1, Ronald Myers, M Elisabeth Del Giudice, Lawrence Pazsat, Michelle Cotterchio, Roberta Howlett, Verna Mai, Patrick Brown, Terrence Sullivan, Linda Rabeneck.   

Abstract

OBJECTIVE: To determine factors that influence awareness of, and readiness to undergo, fecal occult blood testing (FOBT) for colorectal cancer (CRC) screening.
DESIGN: Validated survey designed to ascertain respondents' stages of decision making regarding CRC screening using FOBT.
SETTING: Ontario. PARTICIPANTS: A total of 1013 people 50 years old and older drawn from all regions of the province using a random-digit dialing telephone protocol. MAIN OUTCOME MEASURES: Awareness of FOBT and readiness to undergo it for screening for CRC.
RESULTS: Response rate was 69%. Results indicated that 54% of women and 45% of men had "heard of" FOBT, and 26% of women and 17% of men had heard of it but were still "not considering" FOBT screening. Only 17% of all respondents had "decided to have" FOBT screening. Demographic factors associated with having heard of FOBT were female sex, completion of college or higher education, and being married or living as married. Demographic factors associated with active consideration of FOBT among those who reported awareness of it were male sex and being married or living as married.
CONCLUSION: Many people seemed uninformed about FOBT and not ready to undertake this type of screening. Results of this survey could help guide strategies and develop programs to make eligible people aware of CRC screening using FOBT and to motivate them to undergo testing.

Entities:  

Mesh:

Year:  2009        PMID: 19221081      PMCID: PMC2642507     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

1.  The Next Step Trial: impact of a worksite colorectal cancer screening promotion program.

Authors:  B C Tilley; S W Vernon; R Myers; K Glanz; M Lu; K Hirst; A R Kristal
Journal:  Prev Med       Date:  1999-03       Impact factor: 4.018

2.  Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

3.  Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians.

Authors:  Jasmin A Tiro; Sally W Vernon; Terry Hyslop; Ronald E Myers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

4.  Intention to screen for colorectal cancer among white male employees.

Authors:  R E Myers; S W Vernon; B C Tilley; M Lu; B G Watts
Journal:  Prev Med       Date:  1998 Mar-Apr       Impact factor: 4.018

5.  Adherence to continuous screening for colorectal neoplasia.

Authors:  R E Myers; A M Balshem; T A Wolf; E A Ross; L Millner
Journal:  Med Care       Date:  1993-06       Impact factor: 2.983

6.  Do parents understand immunizations? A national telephone survey.

Authors:  B G Gellin; E W Maibach; E K Marcuse
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

7.  Development and validation of an instrument to measure factors related to colorectal cancer screening adherence.

Authors:  S W Vernon; R E Myers; B C Tilley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-10       Impact factor: 4.254

8.  Modeling adherence to colorectal cancer screening.

Authors:  R E Myers; E Ross; C Jepson; T Wolf; A Balshem; L Millner; H Leventhal
Journal:  Prev Med       Date:  1994-03       Impact factor: 4.018

9.  A population-based estimate of the extent of colorectal cancer screening in Ontario.

Authors:  Linda Rabeneck; Lawrence F Paszat
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

10.  A Canadian national survey of attitudes and knowledge regarding preventive vaccines.

Authors:  Paul Ritvo; Jane Irvine; Neil Klar; Kumanan Wilson; Laura Brown; Karen E Bremner; Aline Rinfret; Robert Remis; Murray D Krahn
Journal:  J Immune Based Ther Vaccines       Date:  2003-11-05
View more
  7 in total

1.  ColonCancerCheck primary care invitation pilot project: patient perceptions.

Authors:  Jill Tinmouth; Paul Ritvo; S Elizabeth McGregor; Jigisha Patel; Crissa Guglietti; Cheryl A Levitt; Lawrence F Paszat; Linda Rabeneck
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

2.  Screening and the family physician.

Authors:  Nicholas Pimlott
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

Review 3.  Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

4.  Predicting breast and colon cancer screening among English-as-a-second-language older Chinese immigrant women to Canada.

Authors:  Laura Todd; Erin Harvey; Laurie Hoffman-Goetz
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

5.  Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; Louise Keogh; Louisa B Flander; Ingrid Winship; Graham G Giles; John L Hopper; Mark A Jenkins
Journal:  Cancer Causes Control       Date:  2012-09-26       Impact factor: 2.506

6.  Family physicians' choices of and opinions on colorectal cancer screening modalities.

Authors:  Michael Zettler; Brent Mollon; Vitor da Silva; Brett Howe; Mark Speechley; Chris Vinden
Journal:  Can Fam Physician       Date:  2010-09       Impact factor: 3.275

7.  Gender differences in attitudes impeding colorectal cancer screening.

Authors:  Paul Ritvo; Ronald E Myers; Lawrence Paszat; Mardie Serenity; Daniel F Perez; Linda Rabeneck
Journal:  BMC Public Health       Date:  2013-05-24       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.